Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasia Khvorova

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Cell|June 10, 2022
Modulation of DNA transcription: The future of ASO therapeutics?Anastasia Khvorova
Nature Reviews. Drug Discovery|April 3, 2024
RNAi-based drug design: considerations and future directionsQi Tang, Anastasia Khvorova
Nature Biotechnology|March 1, 2017
The chemical evolution of oligonucleotide therapies of clinical utilityAnastasia Khvorova, Jonathan K Watts
Nucleic Acid Therapeutics|May 11, 2018
Improving siRNA Delivery In Vivo Through Lipid ConjugationMaire F Osborn, Anastasia Khvorova
Nucleic Acid Therapeutics|March 20, 2024
Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming InnovationJillian Belgrad, Hassan H Fakih, Anastasia Khvorova
Molecular Therapy. Nucleic Acids|July 17, 2023
Asymmetric trichotomous partitioning overcomes dataset limitations in building machine learning models for predicting siRNA efficacyKathryn R Monopoli, Dmitry Korkin, Anastasia Khvorova
Cell|October 22, 2003
Functional siRNAs and miRNAs exhibit strand biasAnastasia Khvorova, Angela Reynolds, Sumedha D Jayasena
Molecular Therapy. Nucleic Acids|August 21, 2020
Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing EfficacySocheata Ly, Dimas Echeverria, Jacquelyn Sousa, et al.
Nucleic Acid Therapeutics|March 25, 2026
The Approval of Redemplo for Familial Chylomicronemia Syndrome and the Many Flavors of GalNAc-OligonucleotidesJulia F Alterman, Katherine Y Gross, Anastasia Khvorova
The Journal of Biological Chemistry|February 27, 2004
Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interferenceFangtian Huang, Anastasia Khvorova, William Marshall, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Cell|June 10, 2022
Modulation of DNA transcription: The future of ASO therapeutics?Anastasia Khvorova
Nature Reviews. Drug Discovery|April 3, 2024
RNAi-based drug design: considerations and future directionsQi Tang, Anastasia Khvorova
Nature Biotechnology|March 1, 2017
The chemical evolution of oligonucleotide therapies of clinical utilityAnastasia Khvorova, Jonathan K Watts
Nucleic Acid Therapeutics|May 11, 2018
Improving siRNA Delivery In Vivo Through Lipid ConjugationMaire F Osborn, Anastasia Khvorova
Nucleic Acid Therapeutics|March 20, 2024
Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming InnovationJillian Belgrad, Hassan H Fakih, Anastasia Khvorova
Molecular Therapy. Nucleic Acids|July 17, 2023
Asymmetric trichotomous partitioning overcomes dataset limitations in building machine learning models for predicting siRNA efficacyKathryn R Monopoli, Dmitry Korkin, Anastasia Khvorova
Cell|October 22, 2003
Functional siRNAs and miRNAs exhibit strand biasAnastasia Khvorova, Angela Reynolds, Sumedha D Jayasena
Molecular Therapy. Nucleic Acids|August 21, 2020
Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing EfficacySocheata Ly, Dimas Echeverria, Jacquelyn Sousa, et al.
Nucleic Acid Therapeutics|March 25, 2026
The Approval of Redemplo for Familial Chylomicronemia Syndrome and the Many Flavors of GalNAc-OligonucleotidesJulia F Alterman, Katherine Y Gross, Anastasia Khvorova
The Journal of Biological Chemistry|February 27, 2004
Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interferenceFangtian Huang, Anastasia Khvorova, William Marshall, et al.
Pageof 16